Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Articles in E-pub version are posted online ahead of regular printed publication.

Snapshot

HBeAg-Positive Grey-Zone Patients: Treatment Beyond Guideline?

Soon Kyu Lee, Jung Hyun Kwon

Received May 29, 2023 Accepted May 30, 2023

DOI: https://doi.org/10.3350/cmh.2023.0185 [Accepted]

View: 9 Download: 1

Correspondence

Navigating Ethical Challenges in AI Application for Healthcare: Developers and Users in Focus

Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng

Received May 27, 2023 Accepted May 30, 2023

DOI: https://doi.org/10.3350/cmh.2023.0182 [Accepted]

View: 17 Download: 2

The Application of GPT-4 in patient education and healthcare delivery

Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng

Received May 27, 2023 Accepted May 30, 2023

DOI: https://doi.org/10.3350/cmh.2023.0183 [Accepted]

View: 12 Download: 1

Editorial

The latest evidence on the impact of fatty liver on liver-related outcomes and mortality in chronic hepatitis B

Xianhua Mao, Lung Yi Mak, Wai-Kay Seto

Received May 21, 2023 Accepted May 26, 2023

DOI: https://doi.org/10.3350/cmh.2023.0173 [Accepted]

View: 17 Download: 2

Original Article

Transarterial Radioembolization versus Tyrosine Kinase Inhibitor in Hepatocellular Carcinoma with Portal Vein Thrombosis

Moon Haeng Hur, Yuri Cho, Do Young Kim, Jae Seung Lee, Gyoung Min Kim, Hyo-Cheol Kim, Dong Hyun Sinn, Dongho Hyun, Han Ah Lee, Yeon Seok Seo, In Joon Lee, Joong-Won Park, Yoon Jun Kim

Received February 27, 2023 Accepted May 24, 2023

DOI: https://doi.org/10.3350/cmh.2023.0076 [Accepted]

View: 22 Download: 2

Review

The Evolving Role of Lenvatinib at the New Era of First-Line HCC Treatment

Landon L. Chan, Stephen L. Chan

Received March 22, 2023 Accepted May 25, 2023

DOI: https://doi.org/10.3350/cmh.2023.0114 [Accepted]

View: 154 Download: 30

Letter to the Editor

Assessing the performance of ChatGPT: Comment

Amnuay Kleebayoon, Viroj Wiwanitkit

Received May 18, 2023 Accepted May 23, 2023

DOI: https://doi.org/10.3350/cmh.2023.0170 [Accepted]

View: 91 Download: 13

Letter regarding “Examining the Accuracy and Reproducibility of ChatGPT in Answering Questions on Cirrhosis and Hepatocellular Carcinoma Management”

Hassam Ali

Received March 26, 2023 Accepted March 27, 2023

DOI: https://doi.org/10.3350/cmh.2023.0120 [Accepted]

View: 187 Download: 24

Is liver biopsy mandatory to identify immune-tolerant phase of chronic hepatitis B?

Joo Hyun Oh, Dong Hyun Sinn

Received April 4, 2023 Accepted April 5, 2023

DOI: https://doi.org/10.3350/cmh.2023.0135 [Accepted]

View: 92 Download: 8

Non-alcoholic fatty liver disease: Definition and subtypes: Is time to change the concept from liver disease to systemic disease?

Seul Ki Han, Soon Koo Baik, Moon Young Kim

Received April 25, 2023 Accepted May 15, 2023

DOI: https://doi.org/10.3350/cmh.2023.0155 [Accepted]

View: 135 Download: 12

Original Article

Treated Chronic Hepatitis B Is a Good Prognostic Factor of Diffuse Large B-Cell Lymphoma

Jeayeon Park, Sung Won Chung, Yun Bin Lee, Hyunjae Shin, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jeonghwan Youk, Ji Yun Lee, Jeong-Ok Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Tae Min Kim, Jeong-Hoon Lee

Received February 13, 2023 Accepted May 16, 2023

DOI: https://doi.org/10.3350/cmh.2023.0057 [Accepted]

View: 185 Download: 20

Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study

Chang Hun Lee, Gwang Hyeon Choi, Hwa Young Choi, Sojung Han, Eun Sun Jang, Young Eun Chon, Young Chang, Kyung-Ah Kim, Do Young Kim, Hyung Joon Yim, Hye-Lin Kim, Sook-Hyang Jeong, In Hee Kim

Received March 16, 2023 Accepted May 12, 2023

DOI: https://doi.org/10.3350/cmh.2023.0110 [Accepted]

View: 133 Download: 14

HCC prediction model performance decrease with long-term antiviral therapy in chronic hepatitis B patients

Xiaoning Wu, Xiaoqian Xu, Jialing Zhou, YaMeng Sun, Huiguo Ding, Wen Xie, Guofeng Chen, Anlin Ma, HongXin Piao, Bingqiong Wang, Shuyan Chen, Tongtong Meng, Xiaojuan Ou, Hwai-I Yang, Jidong Jia, Yuanyuan Kong, Hong You

Received March 27, 2023 Accepted May 10, 2023

DOI: https://doi.org/10.3350/cmh.2023.0121 [Accepted]

View: 210 Download: 24

Letter to the Editor

The upper limit of normal for ALT in males according to AASLD guideline

Halil Haldun Emiroglu

Received March 30, 2023 Accepted April 7, 2023

DOI: https://doi.org/10.3350/cmh.2023.0132 [Accepted]

View: 120 Download: 1

Subtypes of non-alcoholic fatty liver disease in terms of cardiovascular disease and dementia risks

Seogsong Jeong, Yohwan Lim, Su Kyoung Lee, Hyun Wook Han

Received March 29, 2023 Accepted April 5, 2023

DOI: https://doi.org/10.3350/cmh.2023.0129 [Accepted]

View: 159 Download: 17

Original Article

Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and MR imaging

Yoon Jung Hwang, Jae Seok Bae, Youngeun Lee, Bo Yun Hur, Dong Ho Lee, Haeryoung Kim

Received January 29, 2023 Accepted May 6, 2023

DOI: https://doi.org/10.3350/cmh.2023.0034 [Accepted]

View: 223 Download: 26

Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis

Yu Jun Wong, Vy H. Nguyen, Hwai-I Yang, Jie Li, Michael Huan Le, Wan-Jung Wu, Nicole Xinrong Han, Khi Yung Fong, Elizebeth Chen, Connie Wong, Fajuan Rui, Xiaoming Xu, Qi Xue, Xin Yu Hu, Wei Qiang Leow, George Boon-Bee Goh, Ramsey Cheung, Grace Wong, Vincent Wai-Sun Wong, Ming-Whei Yu, Mindie H. Nguyen

Received January 5, 2023 Accepted April 29, 2023

DOI: https://doi.org/10.3350/cmh.2023.0004 [Accepted]

View: 421 Download: 44

Review

KASL Clinical Practice Guidelines for Management of Autoimmune Hepatitis 2022

Received March 1, 2023 Accepted April 3, 2023

DOI: https://doi.org/10.3350/cmh.2023.0087 [Accepted]

View: 199 Download: 41

Hepatorenal Syndrome: Current Concepts and Future Perspectives

Chan-Young Jung, Jai Won Chang

Received January 25, 2023 Accepted April 10, 2023

DOI: https://doi.org/10.3350/cmh.2023.0024 [Accepted]

View: 1852 Download: 722

Original Article

Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma

Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo

Received March 3, 2023 Accepted March 21, 2023

DOI: https://doi.org/10.3350/cmh.2023.0089 [Accepted]

View: 4763 Download: 784 Citations: 3

Review

Acute -on- Chronic liver failure – Terminology, Mechanisms and Management

Vinay Kumar BR, Shiv Kumar Sarin

Received April 16, 2022 Accepted February 25, 2023

DOI: https://doi.org/10.3350/cmh.2022.0103 [Accepted]

View: 883 Download: 230

Safety Considerations for Withdrawal of Nucleos(t)ide Analogues in Patients with Chronic Hepatitis B: First, Do No Harm

Yao-Chun Hsu, Cheng-Hao Tseng, Jia-Horng Kao

Received November 26, 2022 Accepted March 13, 2023

DOI: https://doi.org/10.3350/cmh.2022.0420 [Accepted]

View: 469 Download: 54

Hepatitis B core-related antigen: a novel and promising surrogate biomarker to guide anti-HBV therapy

Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka

Received December 2, 2022 Accepted March 7, 2023

DOI: https://doi.org/10.3350/cmh.2022.0434 [Accepted]

View: 585 Download: 107 Citation: 1

Original Article

Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis

Min Jeong Park, Hayeon Kim, Myeong Gyu Kim, Kyungim Kim

Received October 22, 2022 Accepted March 6, 2023

DOI: https://doi.org/10.3350/cmh.2022.0330 [Accepted]

View: 470 Download: 46

Review

A decade of liver organoids: Advancements in disease modeling

Yue Liu, Jian-Ying Sheng, Chun-Fang Yang, Junjun Ding, Yun-Shen Chan

Received November 29, 2022 Accepted February 28, 2023

DOI: https://doi.org/10.3350/cmh.2022.0428 [Accepted]

View: 3310 Download: 120

Acute hepatitis C virus infection: clinical update and remaining challenges

Chen-Hua Liu, Jia-Horng Kao

Received October 30, 2022 Accepted February 16, 2023

DOI: https://doi.org/10.3350/cmh.2022.0349 [Accepted]

View: 788 Download: 178 Citations: 2

Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection

Chih-Lin Lin, Jia-Horng Kao

Received October 31, 2022 Accepted February 12, 2023

DOI: https://doi.org/10.3350/cmh.2022.0342 [Epub ahead of print]

View: 705 Download: 132

Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity

Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Takashi Niizeki, Takumi Kawaguchi

Received November 9, 2022 Accepted February 9, 2023

DOI: https://doi.org/10.3350/cmh.2022.0391 [Epub ahead of print]

View: 730 Download: 147 Citations: 2

Viewed By 4109	Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
Viewed By 2681	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Viewed By 2433	The independent effect of exercise on biopsy proven non-alcoholic fatty liver disease: A systematic review
Viewed By 2405	Recent updates on the management of autoimmune hepatitis
Viewed By 2402	Management of refractory ascites

Cited By 99	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 42	Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
Cited By 42	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 40	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 38	The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future

Ahead-of-print